Do you know about our history? 🧐 #VennLifeSciences has been a partner in the life science industry for over 25 years. Our commitment to excellence has driven us to where we are today. Thank you to our incredible team, partners, and clients for being a part of our journey. 💡Join us as we continue to innovate and make a difference in the world of drug development! 📜Discover our story and check out our new interactive company timeline here: https://lnkd.in/gNane5j6 #Venn #DrugDevelopment #LifeSciences #History
Venn Life Sciences - part of hVIVO plc’s Post
More Relevant Posts
-
Discovery chemists, ever dream of traveling from “data in” to “data out” along a path that includes entity registration? A DMTA workflow that saves you time and protects your investment? We've built the road. Meet some of its trailblazers on our July 31st webinar, including Steve Unger, Department Head and Director of Informatics at Pliant Therapeutics. Register for *Catalyzing DMTA Information into Insights* at https://lnkd.in/eBwDuFSw #medicinalchemistry #dmta #cheminformatics #drugdiscovery
-
-
Remember to put our next webinar in your diary! All details below ⬇
Join us for our next webinar on Wednesday, 21 August at 12PM (SAST). Jessica Akester, Project Manager at Drug Discovery and Development Centre (H3D), University of Cape Town, will share some insights into managing drug discovery projects. You can find out more and register for the webinar here: https://lnkd.in/dkg562kz #drugdiscovery #drugdevelopment #projectmanagement #webinar
-
-
BD Single-Cell Solutions for Drug Discovery 💡 Looking for deeper insights into drug discovery? BD’s single-cell analysis and multiomics platforms give you the tools to explore cellular heterogeneity at unprecedented resolution. 📍 Come and see me at BD at booth A20 during ELRIG Drug Discovery 2024 and learn how we’re supporting drug discovery across cell therapy and beyond. #Multiomics #SingleCell #CellTherapy #ELRIG2024 #DrugDiscovery #Spectralflow
We're excited to be sponsoring the 2024 ELRIG Drug Discovery Conference in London! Connecting minds, transforming science, empowering the community. Join us on 2nd & 3rd Oct to connect with industry leaders and discover how BD Biosciences is driving the future of drug discovery. We look forward to seeing you there! #BDatELRIG #Celltherapy #ManufacturingQC #BDCellview
-
-
🔬 Heading to ELRIG Drug Discovery 2024? Don’t miss BD Biosciences at booth A20! Learn how our single-cell multiomics solutions are unlocking new insights in drug discovery by revealing the complexity of individual cells. 🚀 Explore how we're empowering researchers to accelerate the development of next-generation therapies. 📅 Stop by booth A20 to discuss how we can support your research needs. See you there! #CellTherapy #SingleCellAnalysis #DrugDiscovery #Multiomics #ELRIG2024
We're excited to be sponsoring the 2024 ELRIG Drug Discovery Conference in London! Connecting minds, transforming science, empowering the community. Join us on 2nd & 3rd Oct to connect with industry leaders and discover how BD Biosciences is driving the future of drug discovery. We look forward to seeing you there! #BDatELRIG #Celltherapy #ManufacturingQC #BDCellview
-
-
Translating Science into Patient Care as SVP, Medical Head International Markets at Bristol Myers Squibb
The video Mark mentions below is great to learn more about protein degradation!
At @Bristol Myers Squibb, we are all in on #TargetedProteinDegradation (TPD) and its potential for patients. As one of our differentiated research platforms, we’re expanding on our legacy in TPD by exploring potential new options across a broad range of diseases. We had great discussions about these advancements during our annual European Scientific Innovation Summit this week. You can learn more about our efforts in TPD here: Science Firsthand: The pathway to drug discovery – Bristol Myers Squibb (bms.com) #BMS_Employee, #EUScientificInnovationSummit
-
-
At @Bristol Myers Squibb, we are all in on #TargetedProteinDegradation (TPD) and its potential for patients. As one of our differentiated research platforms, we’re expanding on our legacy in TPD by exploring potential new options across a broad range of diseases. We had great discussions about these advancements during our annual European Scientific Innovation Summit this week. You can learn more about our efforts in TPD here: Science Firsthand: The pathway to drug discovery – Bristol Myers Squibb (bms.com) #BMS_Employee, #EUScientificInnovationSummit
-
-
Let's meet at #DOT to understand your drug discovery challenges & how we at Jubilant can accelerate your drug discovery journey seamlessly!
Jubilant Biosys is excited to be part of the 22nd Annual Discovery on Target Conference, where we’ll be supporting you every step of the way in your drug discovery journey. Join us at Booth 102 to gain insights on our infrastructure, capabilities and technologies. Meet our team from Business Development: Sanjivi Kudtarkar (US East) and Suseela Gadi (US Midwest), to discover how our innovative solutions can accelerate your R&D efforts. Schedule a meeting to connect with our team: https://lnkd.in/gS6ywSWA #CRO #CRDMO #CDMO #Jubilant #JubilantBiosys #JBL #Drugdiscovey #Boston #US #science #innovation
-
-
🎉 Milestone Moment: 10001 Followers! 🎉 In true palindromic spirit, I’m excited to share that I have reached 10001 followers today! It’s not just about the number; it’s about the incredible journey, partnerships, and knowledge exchange along the way. Thank you to each one of you for being part of this dynamic LinkedIn community. Here’s to growing together, learning from one another, and continuing to drive innovation in life sciences and beyond! Folks like Gary Monk, Brian Galicia, Bora Erdemli, Julien de Salaberry, Dr. Christian Velten, Thomas Hagemeijer, Anup Soans, Dmitry Etin, Dr. Andrée Bates, Jan Beger, Adnan Z., Reza Zahiri, Pascal BOUQUET, Bill Staikos, Luigi Pavia have greatly impacted my understanding of the industry. I thank you all for setting such an inspiring example! To learn more about the projects I am involved with, please feel free to follow The Palindromic. #digitalstrategy #GTMstrategy #digitalhealth #pharmaceuticals #LinkedIn
-
-
Check out this spotlight on our Discovery and Preclinical practice area. A quick video highlighting our practice area leader, Melissa Acevedo, and some recently completed searches. Get in touch with Melissa for anything Discovery and Preclinical: macevedo@prestigescientific.com #discovery #preclinical #biotechcareers #prestigescientific
-
#LabMarket #LifeScienceTools #LabInstruments #LabConsumables #LabServices #DrugDevelopment #bulk: Quarterly data, accurate modeling, funding, customers, persona, segmentation, behavior, trends, products, opportunities.
#WetLab vs. #DryLab: Who Will Secure More Funding from Big Pharma and Life Science Research Institutions? Do we have to extend the pool of major players in #LabInstruments and #LabConsumables with #LabServices and something like DigitalLifeScienceTools n Services? In just two weeks, we will gain solid insights into the funding trends for WET-Labs and DRY-Labs. Will the current downtrend for WET-Labs persist, and will the uptrend for DRY-Labs continue? The upcoming reports from major players such as Thermo Fisher Scientific (#TMO), Danaher Corporation (#DHR), Merck KGaA, #Waters Corporation, #BioRad Laboratories, and #BRKR Corporation will provide crucial data to answer these questions. Stay tuned! I will release preliminary numbers for #LabMarket in early August.
-
